BioCentury
ARTICLE | Company News

Aclara, Tokyo Metropolitan Institute of Medical Science deal

June 21, 2004 7:00 AM UTC

The parties will study breast cancer patient samples in an effort to validate cancer biomarkers detected with ACLA's eTag technology. The deal combines the institute's tumor samples and patient data w...